Evidence map›Paper›PMID 33033656›Full record

ArticleJournal of pathology informatics2020

Deep Learning to Estimate Human Epidermal Growth Factor Receptor 2 Status from Hematoxylin and Eosin-Stained Breast Tissue Images.

Deepak Anand, Nikhil Cherian Kurian, Shubham Dhage, Neeraj Kumar, Swapnil Rane, Peter H Gann, Amit Sethi

Abstract read
In one paragraph

Article in Journal of pathology informatics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Deepak AnandDepartment of Electrical Engineering, IIT Bombay, Mumbai, Maharashtra, India.
Nikhil Cherian KurianDepartment of Electrical Engineering, IIT Bombay, Mumbai, Maharashtra, India.
Shubham DhageDepartment of Electrical Engineering, IIT Bombay, Mumbai, Maharashtra, India.
Neeraj KumarDepartment of Computing Science, University of Alberta, Edmonton, Canada.
Swapnil RaneDepartment of Pathology, Tata Memorial Centre - ACTREC, HBNI, Navi Mumbai, Maharashtra, India.
Peter H GannDepartment of Pathology, University of Illinois, Chicago, USA.
Amit SethiDepartment of Electrical Engineering, IIT Bombay, Mumbai, Maharashtra, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextSeveral therapeutically important mutations in cancers are economically detected using immunohistochemistry (IHC), which highlights the overexpression of specific antigens associated with the mutation. However, IHC panels can be imprecise and relatively expensive in low-income settings. On the other hand, although hematoxylin and eosin (H&E) staining used to visualize the general tissue morphology is a routine and low cost, it does not highlight any specific antigen or mutation.

aimsUsing the human epidermal growth factor receptor 2 (HER2) mutation in breast cancer as an example, we strengthen the case for cost-effective detection and screening of overexpression of HER2 protein in H&E-stained tissue. SETTINGS AND

designWe use computational methods that reliably detect subtle morphological changes associated with the over-expression of mutation-specific proteins directly from H&E images. SUBJECTS AND

methodsWe trained a classification pipeline to determine HER2 overexpression status of H&E stained whole slide images. Our training dataset was derived from a single hospital containing 26 (11 HER2+ and 15 HER2-) cases. We tested the classification pipeline on 26 (8 HER2+ and 18 HER2-) held-out cases from the same hospital and 45 independent cases (23 HER2+ and 22 HER2-) from the TCGA-BRCA cohort. The pipeline was composed of a stain separation module and three deep neural network modules in tandem for robustness and interpretability. STATISTICAL ANALYSIS USED: We evaluate our trained model through area under the curve (AUC)-receiver operating characteristic.

resultsOur pipeline achieved an AUC of 0.82 (confidence interval [CI]: 0.65-0.98) on held-out cases and an AUC of 0.76 (CI: 0.61-0.89) on the independent dataset from TCGA. We also demonstrate the region-level correspondence of HER2 overexpression between a patient's IHC and H&E serial sections.

conclusionsOur work strengthens the case for automatically quantifying the overexpression of mutation-specific proteins in H&E-stained digital pathology, and it highlights the importance of multi-stage machine learning pipelines for added robustness and interpretability.

Indexed as

Breast cancerconvolutional neural networkshistopathologyhuman epidermal growth factor receptor 2immunohistochemistrymutation detectionnucleus detection

Identifiers

PMID33033656
PMCPMC7513777

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.